CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy

J Am Soc Nephrol. 2025 Dec 15. doi: 10.1681/ASN.0000000983. Online ahead of print.ABSTRACTBACKGROUND: Complement activation is involved in IgA nephropathy. We previously identified that genetic deletion of CFHR3 and CFHR1 confers protection against IgA nephropathy by modulating complement activation

Y Yongji Zhang

Restless Legs Syndrome: A Review

JAMA. 2026 Jan 21. doi: 10.1001/jama.2025.23247. Online ahead of print.ABSTRACTIMPORTANCE: Restless legs syndrome (RLS) is a sleep-related movement disorder that affects approximately 3% of US adults to a clinically significant extent and can cause substantial sleep disturbance.OBSERVATIONS: Restles

J John W Winkelman

Patient Engagement With Home Blood Pressure Monitoring

JAMA Cardiol. 2026 Jan 21. doi: 10.1001/jamacardio.2025.5196. Online ahead of print.ABSTRACTIMPORTANCE: Home blood pressure monitoring (HBPM) is essential and universally recommended for hypertension management, but patterns of real-world patient engagement with HBPM have not been studied and remain

O Ozan Unlu

Addressing Hypertension Treatment Disparities Via Renal Denervation

Curr Hypertens Rep. 2026 Jan 21;28(1):9. doi: 10.1007/s11906-025-01359-y.ABSTRACTPURPOSE OF REVIEW: To discuss available data on renal denervation (RDN) for treating hypertension and how expanding access to RDN may improve rates of controlled hypertension while helping address hypertension treatment

B Bernardo F Spiazzi